A Look At Ironwood Pharmaceuticals (IRWD) Valuation After Q4 2025 Results And 2026 Revenue Guidance [Yahoo! Finance]
Ironwood Pharmaceuticals, Inc. - Class A (IRWD)
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ironwoodpharma.com
Company Research
Source: Yahoo! Finance
Q4 results and 2026 guidance in focus Ironwood Pharmaceuticals (IRWD) has drawn fresh attention after reporting its Q4 and full year 2025 results, alongside reiterating 2026 total revenue guidance of US$450 million to US$475 million. The latest report combined a Q4 sales decline and a small quarterly net loss with higher full year net income. This gives investors a mixed snapshot to weigh against the reiterated 2026 outlook. See our latest analysis for Ironwood Pharmaceuticals. The Q4 results and reiterated 2026 revenue guidance have come alongside sharp share price swings. There was an 8.93% 1 day share price return following a 28.79% 30 day share price decline, while the 1 year total shareholder return of 125.93% contrasts with a 67.55% total shareholder return decline over three years. If Ironwood's volatility has you thinking about risk and reward in other areas of the market, it could be a good moment to check out 29 healthcare AI stocks as a curated starting point for
Show less
Read more
Impact Snapshot
Event Time:
IRWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRWD alerts
High impacting Ironwood Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
IRWD
News
- Ironwood Pharmaceuticals (IRWD) had its "hold" rating reaffirmed by Jefferies Financial Group Inc..MarketBeat
- Ironwood Pharmaceuticals (IRWD) had its price target raised by Citizens Jmp from $8.00 to $10.00. They now have a "market outperform" rating on the stock.MarketBeat
- Ironwood Pharmaceuticals Inc (IRWD) Q4 2025 Earnings Call Highlights: Strong LINZESS Sales and ... [Yahoo! Finance]Yahoo! Finance
- Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 OutlookBusiness Wire
IRWD
Earnings
- 2/25/26 - Miss
IRWD
Sec Filings
- 2/26/26 - Form 10-K
- 2/25/26 - Form 4
- 2/25/26 - Form 4
- IRWD's page on the SEC website